Market Overview:
The global animal model for testing market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth of the market can be attributed to the increasing use of animal models in academic and research institutes, and pharmaceutical and biotechnology companies. Additionally, the growing demand for genetically modified animals is also contributing to the growth of this market. However, stringent regulations regarding animal testing are restraining the growth of this market. On the basis of type, rats accounted for a major share of the global animal model for testing market in 2017. This can be attributed to their low cost and easy availability compared with other animals such as mice and rabbits.
Product Definition:
A model is an object or system that is used to represent another, often larger, object or system. In the scientific world, a model can be anything from a mathematical equation to a living organism. When scientists use models in their research, they are able to learn more about the real thing by studying the model. In many cases, scientists must first study how something works in a simplified form before they can apply that knowledge to something more complex.
Animal models are used extensively in biomedical research and drug development. They provide researchers with an opportunity to study human diseases and test potential treatments in a controlled environment. Animal models are also used to understand how organisms develop and respond to environmental stimuli and genetic modifications.
Rats:
Rats are used in research for testing various diseases and conditions because of their characteristics such as small size, low cost, adaptability & susceptibility to infections. Rodents have been used as models for studying human disease since the beginning of recorded history. The use of rodents in research has increased over the past few decades owing to technological advancements and a rise in funding from government agencies.
Mice:
Mice and rats are two most commonly used animal models for testing market products. Mice is the preferred choice of model among researchers as it is easy to handle, breed and can be tested in a relatively short time span. On the other hand, rats have been found to be more accurate in predicting human response but take longer duration for finishing the study.
Application Insights:
The academic and research institutes segment held the largest share of more than 60.0% in 2017. The pharmaceutical and biotechnology companies followed the academic and research institutes in terms of usage of animal models for drug discovery, clinical testing as well as product development. In addition, this segment is expected to witness lucrative growth owing to increasing government funding for biomedical research coupled with growing emphasis on translational medicine by regulatory authorities across various regions including North America, Europe, Asia Pacific and Middle East & Africa.
Rising demand for advanced therapeutics driven by unmet medical needs is one of the key factors driving product adoption across various segments including academic institutions/research laboratories, pharmaceutical companies & biotechnology firms etc., However; resistance from ethical committees at these organizations against using animals during pre-clinical trials may pose a major roadblock towards market penetration in near future.
Regional Analysis:
North America dominated the global animal model market in 2017. This can be attributed to the presence of a large number of academic and research institutes, which use animals for various purposes such as toxicology studies, drug screening, and disease modeling. Moreover, these organizations are also involved in collaborations with pharmaceutical companies for developing novel drugs targeting target diseases. Thus rising demand from both academic and industrial sectors is anticipated to drive the North American market over the forecast period.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing awareness about alternative methods used by researchers for testing products as well as animals’ welfare during tests. Furthermore government support through funding programs aimed at promoting R&D activities pertaining to veterinary health & hygiene has also contributed significantly towards regional growth since 2009 (Government of India). Such factors are expected propel Asia Pacific into a leading position by 2030 thereby driving revenue across all regions mentioned above except Europe where U.K.
Growth Factors:
- Increasing demand for animal models in biomedical research and drug discovery
- Rising prevalence of chronic diseases and increasing R&D expenditure by pharmaceutical companies
- Technological advancements in the field of animal modeling
- Growing number of CROs providing preclinical services
- Increasing awareness about the benefits of using animal models for testing
Scope Of The Report
Report Attributes
Report Details
Report Title
Animal Model for Testing Market Research Report
By Type
Rats, Mice, Others
By Application
Academic & Research Institutes, Pharmaceutical & Biotechnology Companies
By Companies
Charles River Laboratories, Envigo, Taconic Biosciences, Jackson Laboratory, Crown Biosciences, Shanghai SLAC, Shangghai Modelorg, GenOway, Syngene International, Psychogenics, Pharmaron, Pharmalegacy, Horizon Discovery Group, Vitalstar Biotechnology
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Animal Model for Testing Market Report Segments:
The global Animal Model for Testing market is segmented on the basis of:
Types
Rats, Mice, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Academic & Research Institutes, Pharmaceutical & Biotechnology Companies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Charles River Laboratories
- Envigo
- Taconic Biosciences
- Jackson Laboratory
- Crown Biosciences
- Shanghai SLAC
- Shangghai Modelorg
- GenOway
- Syngene International
- Psychogenics
- Pharmaron
- Pharmalegacy
- Horizon Discovery Group
- Vitalstar Biotechnology
Highlights of The Animal Model for Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Rats
- Mice
- Others
- By Application:
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Animal Model for Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Animal models are used to test the safety and effectiveness of new medications, medical devices, or treatments.
Some of the key players operating in the animal model for testing market are Charles River Laboratories, Envigo, Taconic Biosciences, Jackson Laboratory, Crown Biosciences, Shanghai SLAC, Shangghai Modelorg, GenOway, Syngene International, Psychogenics, Pharmaron, Pharmalegacy, Horizon Discovery Group, Vitalstar Biotechnology.
The animal model for testing market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Animal Model for Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Animal Model for Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Animal Model for Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Animal Model for Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Animal Model for Testing Market Size & Forecast, 2020-2028
4.5.1 Animal Model for Testing Market Size and Y-o-Y Growth
4.5.2 Animal Model for Testing Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Rats
5.2.2 Mice
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Academic & Research Institutes
6.2.2 Pharmaceutical & Biotechnology Companies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Animal Model for Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Animal Model for Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Rats
9.6.2 Mice
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Academic & Research Institutes
9.10.2 Pharmaceutical & Biotechnology Companies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Rats
10.6.2 Mice
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Academic & Research Institutes
10.10.2 Pharmaceutical & Biotechnology Companies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Rats
11.6.2 Mice
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Academic & Research Institutes
11.10.2 Pharmaceutical & Biotechnology Companies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Rats
12.6.2 Mice
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Academic & Research Institutes
12.10.2 Pharmaceutical & Biotechnology Companies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Rats
13.6.2 Mice
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Academic & Research Institutes
13.10.2 Pharmaceutical & Biotechnology Companies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Animal Model for Testing Market: Competitive Dashboard
14.2 Global Animal Model for Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Charles River Laboratories
14.3.2 Envigo
14.3.3 Taconic Biosciences
14.3.4 Jackson Laboratory
14.3.5 Crown Biosciences
14.3.6 Shanghai SLAC
14.3.7 Shangghai Modelorg
14.3.8 GenOway
14.3.9 Syngene International
14.3.10 Psychogenics
14.3.11 Pharmaron
14.3.12 Pharmalegacy
14.3.13 Horizon Discovery Group
14.3.14 Vitalstar Biotechnology
